Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: A two-year follow-up study

Hiroshi Tatsumi, Shutaro Nakaaki, Katsuyoshi Torii, Yoshihiro Shinagawa, Norio Watanabe, Yoshie Murata, Junko Sato, Masaru Mimura, Toshiaki A. Furukawa

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

To examine the effect of neuropsychiatric symptoms on longitudinal changes in the quality of life (QOL) of patients with Alzheimer disease (AD). Methods: First, we investigated whether neuropsychiatric symptoms at baseline predict changes in the QOL of AD patients over time. Then we examined the associations between changes in neuropsychiatric symptoms and changes in QOL. QOL was assessed using the Japanese version of the Quality of Life-Alzheimer Disease (QOL-AD) scale and other clinical instruments [the Mini-Mental State Examination, The Neuropsychiatry Inventory (NPI)] at baseline and again two years later in 96 AD patients among 140 AD patients at baseline. We performed a multiple regression analysis of the baseline QOL-AD score, NPI score (mood, psychosis, and euphoria factor), Mini-Mental State Examination score, and other clinical instrument variables (e.g. Activities-of-Daily-Living scores) to determine their contribution to the change in QOL-AD score. Results: While the total QOL-AD score based on the patients' responses did not change significantly, the total QOL-AD score derived from the caregivers' responses declined. Both the Activities-of-Daily-Living score and the mood factor of the NPI score predicted the change in the QOL-AD score as assessed by the caregivers' responses. In addition, there was a significant correlation between the changes in two factors of the NPI, i.e. the mood and psychosis factor, and the changes in the QOL-AD score based on the caregivers' responses. Conclusions: The presence of specific neuropsychiatric symptoms (mood and psychosis symptoms) was associated with changes in the QOL of AD patients during the follow-up period.

Original languageEnglish
Pages (from-to)374-384
Number of pages11
JournalPsychiatry and Clinical Neurosciences
Volume63
Issue number3
DOIs
Publication statusPublished - 2009 Jun
Externally publishedYes

Fingerprint

Alzheimer Disease
Quality of Life
Neuropsychiatry
Psychotic Disorders
Caregivers
Equipment and Supplies
Activities of Daily Living
Regression Analysis

Keywords

  • Alzheimer disease
  • Longitudinal study
  • Neuropsychiatric symptoms
  • QOL-AD
  • Quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients : A two-year follow-up study. / Tatsumi, Hiroshi; Nakaaki, Shutaro; Torii, Katsuyoshi; Shinagawa, Yoshihiro; Watanabe, Norio; Murata, Yoshie; Sato, Junko; Mimura, Masaru; Furukawa, Toshiaki A.

In: Psychiatry and Clinical Neurosciences, Vol. 63, No. 3, 06.2009, p. 374-384.

Research output: Contribution to journalArticle

Tatsumi, Hiroshi ; Nakaaki, Shutaro ; Torii, Katsuyoshi ; Shinagawa, Yoshihiro ; Watanabe, Norio ; Murata, Yoshie ; Sato, Junko ; Mimura, Masaru ; Furukawa, Toshiaki A. / Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients : A two-year follow-up study. In: Psychiatry and Clinical Neurosciences. 2009 ; Vol. 63, No. 3. pp. 374-384.
@article{dd51385ac3d944afab01e7bfaffff082,
title = "Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: A two-year follow-up study",
abstract = "To examine the effect of neuropsychiatric symptoms on longitudinal changes in the quality of life (QOL) of patients with Alzheimer disease (AD). Methods: First, we investigated whether neuropsychiatric symptoms at baseline predict changes in the QOL of AD patients over time. Then we examined the associations between changes in neuropsychiatric symptoms and changes in QOL. QOL was assessed using the Japanese version of the Quality of Life-Alzheimer Disease (QOL-AD) scale and other clinical instruments [the Mini-Mental State Examination, The Neuropsychiatry Inventory (NPI)] at baseline and again two years later in 96 AD patients among 140 AD patients at baseline. We performed a multiple regression analysis of the baseline QOL-AD score, NPI score (mood, psychosis, and euphoria factor), Mini-Mental State Examination score, and other clinical instrument variables (e.g. Activities-of-Daily-Living scores) to determine their contribution to the change in QOL-AD score. Results: While the total QOL-AD score based on the patients' responses did not change significantly, the total QOL-AD score derived from the caregivers' responses declined. Both the Activities-of-Daily-Living score and the mood factor of the NPI score predicted the change in the QOL-AD score as assessed by the caregivers' responses. In addition, there was a significant correlation between the changes in two factors of the NPI, i.e. the mood and psychosis factor, and the changes in the QOL-AD score based on the caregivers' responses. Conclusions: The presence of specific neuropsychiatric symptoms (mood and psychosis symptoms) was associated with changes in the QOL of AD patients during the follow-up period.",
keywords = "Alzheimer disease, Longitudinal study, Neuropsychiatric symptoms, QOL-AD, Quality of life",
author = "Hiroshi Tatsumi and Shutaro Nakaaki and Katsuyoshi Torii and Yoshihiro Shinagawa and Norio Watanabe and Yoshie Murata and Junko Sato and Masaru Mimura and Furukawa, {Toshiaki A.}",
year = "2009",
month = "6",
doi = "10.1111/j.1440-1819.2009.01955.x",
language = "English",
volume = "63",
pages = "374--384",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients

T2 - A two-year follow-up study

AU - Tatsumi, Hiroshi

AU - Nakaaki, Shutaro

AU - Torii, Katsuyoshi

AU - Shinagawa, Yoshihiro

AU - Watanabe, Norio

AU - Murata, Yoshie

AU - Sato, Junko

AU - Mimura, Masaru

AU - Furukawa, Toshiaki A.

PY - 2009/6

Y1 - 2009/6

N2 - To examine the effect of neuropsychiatric symptoms on longitudinal changes in the quality of life (QOL) of patients with Alzheimer disease (AD). Methods: First, we investigated whether neuropsychiatric symptoms at baseline predict changes in the QOL of AD patients over time. Then we examined the associations between changes in neuropsychiatric symptoms and changes in QOL. QOL was assessed using the Japanese version of the Quality of Life-Alzheimer Disease (QOL-AD) scale and other clinical instruments [the Mini-Mental State Examination, The Neuropsychiatry Inventory (NPI)] at baseline and again two years later in 96 AD patients among 140 AD patients at baseline. We performed a multiple regression analysis of the baseline QOL-AD score, NPI score (mood, psychosis, and euphoria factor), Mini-Mental State Examination score, and other clinical instrument variables (e.g. Activities-of-Daily-Living scores) to determine their contribution to the change in QOL-AD score. Results: While the total QOL-AD score based on the patients' responses did not change significantly, the total QOL-AD score derived from the caregivers' responses declined. Both the Activities-of-Daily-Living score and the mood factor of the NPI score predicted the change in the QOL-AD score as assessed by the caregivers' responses. In addition, there was a significant correlation between the changes in two factors of the NPI, i.e. the mood and psychosis factor, and the changes in the QOL-AD score based on the caregivers' responses. Conclusions: The presence of specific neuropsychiatric symptoms (mood and psychosis symptoms) was associated with changes in the QOL of AD patients during the follow-up period.

AB - To examine the effect of neuropsychiatric symptoms on longitudinal changes in the quality of life (QOL) of patients with Alzheimer disease (AD). Methods: First, we investigated whether neuropsychiatric symptoms at baseline predict changes in the QOL of AD patients over time. Then we examined the associations between changes in neuropsychiatric symptoms and changes in QOL. QOL was assessed using the Japanese version of the Quality of Life-Alzheimer Disease (QOL-AD) scale and other clinical instruments [the Mini-Mental State Examination, The Neuropsychiatry Inventory (NPI)] at baseline and again two years later in 96 AD patients among 140 AD patients at baseline. We performed a multiple regression analysis of the baseline QOL-AD score, NPI score (mood, psychosis, and euphoria factor), Mini-Mental State Examination score, and other clinical instrument variables (e.g. Activities-of-Daily-Living scores) to determine their contribution to the change in QOL-AD score. Results: While the total QOL-AD score based on the patients' responses did not change significantly, the total QOL-AD score derived from the caregivers' responses declined. Both the Activities-of-Daily-Living score and the mood factor of the NPI score predicted the change in the QOL-AD score as assessed by the caregivers' responses. In addition, there was a significant correlation between the changes in two factors of the NPI, i.e. the mood and psychosis factor, and the changes in the QOL-AD score based on the caregivers' responses. Conclusions: The presence of specific neuropsychiatric symptoms (mood and psychosis symptoms) was associated with changes in the QOL of AD patients during the follow-up period.

KW - Alzheimer disease

KW - Longitudinal study

KW - Neuropsychiatric symptoms

KW - QOL-AD

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=65649127240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649127240&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2009.01955.x

DO - 10.1111/j.1440-1819.2009.01955.x

M3 - Article

C2 - 19566770

AN - SCOPUS:65649127240

VL - 63

SP - 374

EP - 384

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 3

ER -